Logo Logo
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 4

Zeitschriftenartikel

Simpson, Eric L.; Pink, Andrew E.; Blauvelt, Andrew; Gooderham, Melinda; Armstrong, April W.; Worm, Margitta; Katoh, Norito; Peris, Ketty; Puig, Luis; Barbarot, Sébastien; Mark, Thomas; Steffensen, Louise Abildgaard; Tindberg, Ann-Marie und Wollenberg, Andreas ORCID logoORCID: https://orcid.org/0000-0003-0177-8722 (2023): Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials. In: American Journal of Clinical Dermatology, Bd. 24, Nr. 6: S. 939-952 [PDF, 2MB]

Paller, Amy S.; Wollenberg, Andreas; Siegfried, Elaine; Thaci, Diamant; Cork, Michael J.; Arkwright, Peter D.; Gooderham, Melinda; Sun, Xian; O'Malley, John T.; Khokhar, Faisal A.; Vakil, Jignesh; Bansal, Ashish; Rosner, Karli; Shumel, Brad und Levit, Noah A. (2021): Laboratory Safety of Dupilumab in Patients Aged 6-11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial. In: Pediatric Drugs, Bd. 23, Nr. 5: S. 515-527

Silverberg, Jonathan I.; Guttman-Yassky, Emma; Gooderham, Melinda; Worm, Margitta; Rippon, Stephanie; O'Quinn, Sean; Merwe, Rene van der; Kragh, Nana; Kurbasic, Azra und Wollenberg, Andreas (2021): Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis A phase 2b randomized study. In: Annals of Allergy Asthma & Immunology, Bd. 126, Nr. 5: S. 576-583

Paller, Amy S.; Siegfried, Elaine C.; Thaci, Diamant; Wollenberg, Andreas; Cork, Michael J.; Arkwright, Peter D.; Gooderham, Melinda; Beck, Lisa A.; Boguniewicz, Mark; Sher, Lawrence; Weisman, Jamie; O'Malley, John T.; Patel, Naimish; Hardin, Megan; Graham, Neil M. H.; Ruddy, Marcella; Sun, Xian; Davis, John D.; Kamal, Mohamed A.; Khokhar, Faisal A.; Weinreich, David M.; Yancopoulos, George D.; Beazley, Bethany; Bansal, Ashish und Shumel, Brad (2020): Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial. In: Journal of the American Academy of Dermatology, Bd. 83, Nr. 5: S. 1282-1293

Diese Liste wurde am Sat Mar 8 19:39:44 2025 CET erstellt.